Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2016-05-10 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SORNAC (19290), Correze
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE PRIOUX : revenue, balance sheet and financial ratios
PHARMACIE PRIOUX is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SORNAC (19290),
this company of category PME
shows in 2022 a revenue of 1.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE PRIOUX (SIREN 820194454)
Indicator
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
1 161 505 €
N/C
N/C
N/C
N/C
N/C
Net income
4 778 €
9 999 €
-70 729 €
37 014 €
20 694 €
37 635 €
95 286 €
EBITDA
N/C
28 272 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
0.9%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE PRIOUX generates positive net income of 5 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2023: 95 k€ -> 5 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
4 778 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 265%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 19%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
264.718%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
19.09%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
Debt ratio
525.388
355.335
299.894
222.615
388.855
337.468
264.718
Financial autonomy
13.067
18.128
20.939
25.233
16.286
17.834
19.09
Repayment capacity
None
None
None
None
None
20.192
None
Cash flow / Revenue
None%
None%
None%
None%
None%
1.772%
None%
Sector positioning
Debt ratio
264.722023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.22
Average
In 2023, the debt ratio of PHARMACIE PRIOUX (264.72) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
19.09%2023
2021
2022
2023
Q1: 28.71%
Med: 48.51%
Q3: 68.18%
Average
In 2023, the financial autonomy of PHARMACIE PRIOUX (19.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
20.19 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Watch
In 2022, the repayment capacity of PHARMACIE PRIOUX (20.19) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 52.35. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
52.35
Liquidity indicators evolution PHARMACIE PRIOUX
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
143.005
140.509
121.3
125.559
84.882
80.615
52.35
Interest coverage
None
None
None
None
None
26.358
None
Sector positioning
Liquidity ratio
52.352023
2021
2022
2023
Q1: 135.26
Med: 189.75
Q3: 270.27
Watch-5 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE PRIOUX (52.35) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
26.36x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of PHARMACIE PRIOUX (26.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE PRIOUX
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
Operating WCR
0 €
0 €
0 €
0 €
0 €
93 083 €
0 €
Inventory turnover (days)
0
0
0
0
0
28
0
Customer payment term (days)
0
0
0
0
0
12
0
Supplier payment term (days)
0
0
0
0
0
40
0
Positioning of PHARMACIE PRIOUX in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE PRIOUX is estimated at
56 377 €
(range 34 286€ - 79 254€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
34k€56k€79k€
56 377 €Range: 34 286€ - 79 254€
NAF 5 année 2023
Valuation method used
Net Income Multiple
4 778 €
×
11.8x
=56 378 €
Range: 34 286€ - 79 255€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE PRIOUX with other companies in the same sector:
The revenue of PHARMACIE PRIOUX in 2022 is 1.2 M€.
Is PHARMACIE PRIOUX profitable?
Yes, PHARMACIE PRIOUX generated a net profit of 5 k€ in 2023.
Where is the headquarters of PHARMACIE PRIOUX ?
The headquarters of PHARMACIE PRIOUX is located in SORNAC (19290), in the department Correze.
Where to find the tax return of PHARMACIE PRIOUX ?
The tax return of PHARMACIE PRIOUX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE PRIOUX operate?
PHARMACIE PRIOUX operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart